Nobivac LoVo L4 RSSAuthorisedThis medicine is authorised for use in the European Unioncanine leptospirosis vaccine (inactivated)MedicineVeterinaryAuthorised
Page contents OverviewProduct detailsAuthorisation detailsAssessment historyNews on Nobivac LoVo L4More information on Nobivac LoVo L4Application under evaluationCVMP opinionEuropean Commission decisionOverviewUp-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information websiteProduct details Name of medicine Nobivac LoVo L4 Active substance Leptospira interrogans, serogroup Australis, serovar Bratislava, strain As-05-073, Inactivated,Leptospira interrogans, serogroup Canicola, serovar Portland-vere, strain Ca-12-000, Inactivated,Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Copenhageni, strain Ic-02-001, Inactivated,Leptospira kirschneri, serogroup Grippotyphosa, serovar Dadas, strain GR-01-005, Inactivated, International non-proprietary name (INN) or common name canine leptospirosis vaccine (inactivated) Authorisation details EMA product number EMEA/V/C/005628 Assessment historyInitial marketing authorisation documentsCVMP summary of positiv eopinion for Nobivac LoVo L4Reference Number: EMA/CVMP/424834/2023 English (EN) (141.37 KB - PDF)First published: 06/10/2023ViewNews on Nobivac LoVo L4Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 10-12 June 202513/06/2025Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 21-22 May 202424/05/2024More information on Nobivac LoVo L4Nobivac LoVo L4 - opinion on variation to marketing authorisationThis page was last updated on 03/04/2024Share this page